articaine hydrochloride · Thea Pharma · NDA 218643
Cyklx
Earliest generic entry, as listed
27 Mar 2039
No marketed reference-listed strength; date taken from all listed strengths.
Blocked by patent: US 11096922, US 11826347, US 12403126.
Listed patents · 3 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11096922 | product, use U-4423 | 27 Mar 2039 |
| US 11826347 | product, use U-4423 | 27 Mar 2039 |
| US 12403126 | product, use U-4422 | 27 Mar 2039 |
Exclusivities · 1 unexpired
| NP | new product | 15 Aug 2028 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 218643 · 001 · RLD · discontinued | solution/drops, ophthalmic | EQ 8% BASE | 27 Mar 2039 |